LIVE
NIFTY 50—SENSEX—BANK NIFTY—FINNIFTY—INDIA VIX—NIFTY IT—NIFTY AUTO—NIFTY MID—GIFT NIFTY—USD/INR—NIFTY 50—SENSEX—BANK NIFTY—FINNIFTY—INDIA VIX—NIFTY IT—NIFTY AUTO—NIFTY MID—GIFT NIFTY—USD/INR—NIFTY 50—SENSEX—BANK NIFTY—FINNIFTY—INDIA VIX—NIFTY IT—NIFTY AUTO—NIFTY MID—GIFT NIFTY—USD/INR—
Login☆ WatchlistAPI Docs
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommodities
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth
Language
Englishहिन्दीગુજરાતીमराठी

SUVEN

NSEBSE
Suven Life Sciences Limited
Healthcare· Healthcare Services· INE495B01038· Scrip: 530239
ENहिन्दीગુજરાતીमराठी
₹208.00
▲ 11.92 (+6.08%)
20/4/2026, 10:29:40 pm
NSE
₹208.00
▲ 11.92
+6.08%
BSE
₹209.35
▲ 1.45
+0.00%
12216621025429805-0206-2708-2510-2312-1902-1804-2704-30
244 trading days · 1Y period
TODAY
Open197.90
High217.50
Low196.08
Prev Close196.08
Volume26.37Cr
Value₹1.0Cr
L: 196.08H: 217.50
52 WEEK
Low₹120.12
High₹299.99
49% of 52W range
Info
Face Value₹1
Listed2003-10-23
ISININE495B01038
SeriesB
BSE Scrip530239

Key Metrics

1D
-3.67%
1W
+0.81%
1M
+62.11%
3M
+45.90%
6M
+9.32%
Valuation
P/Sales483.87
Mkt Cap₹3665 Cr
Growth (QoQ)
Revenue-37.43%
PAT+21.21%
EPS+21.15%
Profitability
Net Margin-2429.8%
TTM Net M.-1623.5%
Dividend
Yield0.72%
Growth+0.00%
TTM EBITDA
₹-118 Cr
TTM PAT
₹-123 Cr
TTM EPS
₹-5.63
Rev/Share
₹0.3

Quarterly Financials

Revenue
EBITDA
PAT
EPS
0 Cr1 Cr2 Cr2 Cr3 Cr22-1223-0323-0923-1224-0324-0624-0924-12₹-2.9₹-1.2₹-0.6₹-1.9₹-1.2₹-0.3₹-2.3₹-1.8
QuarterRevenueExpensesEBITDAPBTPATEPS
2024-12-312 Cr42 Cr-38 Cr-39 Cr-39 Cr₹-1.79
2024-09-303 Cr56 Cr-48 Cr-50 Cr-50 Cr₹-2.27
2024-06-301 Cr13 Cr-6 Cr-8 Cr-8 Cr₹-0.35
2024-03-312 Cr34 Cr-26 Cr-28 Cr-27 Cr₹-1.22
2023-12-312 Cr50 Cr-40 Cr-42 Cr-42 Cr₹-1.92
2023-09-303 Cr28 Cr-11 Cr-13 Cr-13 Cr₹-0.58
2023-03-313 Cr36 Cr-26 Cr-28 Cr-28 Cr₹-1.17
2022-12-313 Cr56 Cr-49 Cr-51 Cr-51 Cr₹-2.90

Shareholding Pattern

CURRENT — 2026-03-31
70.2%PROMOTER
Promoter70.2%
FII0.9%
DII4.6%
Public29.9%
PROMOTER HOLDING TREND
70.3%24-1270.3%25-0367.4%25-0967.4%25-1270.2%26-0370.2%26-03

Corporate Actions

Ex-DateTypePurpose
2024-07-30OtherAnnual General Meeting
2023-08-02OtherAnnual General Meeting
2022-10-17RightsRights 1:2 @ Premium Rs 54/-
2022-07-29OtherAnnual General Meeting
2021-08-02Other Annual General Meeting
2020-09-11Other Annual General Meeting
2020-01-21Demerger Demerger
2019-08-08Other Annual General Meeting
2019-02-14Dividend Interim Dividend - Rs 1.50 Per Share
2018-08-09Other Annual General Meeting
2018-02-06Dividend Interim Dividend - Rs 1.50 Per Share (Purpose Revised)
2017-08-09Other Annual General Meeting
2017-02-08Dividend Interim Dividend Re 1 Per Share
2016-08-04Other Annual General Meeting
2016-03-14Dividend Interim Dividend - Re 1/- Per Share / Special Dividend - Re 1/- Per Share (Purpose Revised)
2015-07-23DividendAnnual General Meeting/Dividend - Re 0.60/- Per Share
2014-07-24DividendAnnual General Meeting /Final Dividend - Re 0.50/- Per Share + Special Dividend - Rs 2/- Per Share
2013-08-01DividendAnnual General Meeting / Dividend - Re.0.30/- Per Equity Share
2012-09-17DividendAnnual General Meeting And Dividend Re.0.30 Per Share
2011-08-01DividendAnnual General Meeting And Dividend Re.0.25 Per Share

Earnings Transcripts

Suven Life Sciences Limited has informed the Exchange regarding Investor Presentation
14 Nov 2019NSE5K chars
Read →
Suven Life Sciences Limited has informed the Exchange regarding Investor Presentation
14 Aug 2019NSE4K chars
Read →
Suven Life Sciences Limited has informed the Exchange regarding Investor Presentation
25 May 2019NSE6K chars
Read →
Suven Life Sciences Limited has informed the Exchange regarding Investor Presentation (Corrected)
5 Feb 2019NSE5K chars
Read →
Suven Life Sciences Limited has informed the Exchange regarding Investor Presentation
5 Feb 2019NSE5K chars
Read →
Suven Life Sciences Limited has informed the Exchange regarding Investor Presentation
30 Jan 2018NSE
Read →
Suven Life Sciences Limited has informed the Exchange that the Company has on February 15, 2016 arra...
15 Feb 2016NSE
Read →

Price History

DateOpenHighLowCloseVolume
2026-04-30215.50216.51209.35211.882.32L
2026-04-29220.80225.25216.20217.333.64L
2026-04-28214.10229.69214.10218.6010.16L
2026-04-27202.05218.90202.05211.606.43L
2026-04-24207.66209.10200.25202.052.84L
2026-04-23213.00214.78205.55207.663.33L
2026-04-22210.50215.89208.00212.622.82L
2026-04-21210.00217.00208.00210.504.82L
2026-04-20197.90217.50196.08210.1813.68L
2026-04-17195.93201.50193.60196.084.56L
2026-04-16197.38201.36191.50195.934.38L
2026-04-15195.75197.00189.71191.923.82L
2026-04-13190.00195.39186.60190.404.93L
2026-04-10179.90202.54179.50195.5222.80L
2026-04-09170.00182.50167.03177.987.15L
2026-04-08174.00174.00167.05169.064.41L
2026-04-07165.00171.85164.01166.875.40L
2026-04-02143.43162.00140.30157.9610.90L
2026-04-01139.50148.95135.50147.439.15L
2026-03-27131.98136.00128.00130.197.23L
2026-03-25131.74138.00131.51133.875.22L
2026-03-24131.41131.41124.11129.144.94L
2026-03-20135.71138.01132.65134.033.05L
2026-03-19136.85137.48132.00133.103.20L
2026-03-18138.11146.35137.50138.105.81L
2026-03-17137.69138.80135.20137.382.23L
2026-03-16137.61142.60134.79137.113.51L
2026-03-13137.40141.29135.04137.614.32L
2026-03-12139.15141.50136.35136.725.38L
2026-03-11145.63148.00140.61141.334.64L

Frequently Asked Questions

About

Suven Life Sciences Limited is a clinical-stage biopharmaceutical company focused on acquiring, developing, and commercializing novel therapeutics for various diseases. Key products and services include oncology, immunology, and neuroscience-focused drug candidates, with several in late-stage development. Notably, the company has been involved in significant partnerships and acquisitions to expand its pipeline and market presence.

BOARD OF DIRECTORS
Rangaswamy Naidu Maripuri
Independent Director
DEPARTED
Santanu Mukherjee
Independent Director